BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29917273)

  • 1. Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Tornic J; Sartori AM; Gajewski JB; Cox A; Schneider MP; Youssef NA; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2018 Nov; 37(8):2315-2322. PubMed ID: 29917273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2018 Jan; 37(1):67-82. PubMed ID: 28618110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Schneider MP; Tornic J; Sýkora R; Abo Youssef N; Mordasini L; Krhut J; Chartier-Kastler E; Davies M; Gajewski J; Schurch B; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2019 Aug; 38(6):1482-1491. PubMed ID: 31099113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.
    Abo Youssef N; Schneider MP; Mordasini L; Ineichen BV; Bachmann LM; Chartier-Kastler E; Panicker JN; Kessler TM
    BJU Int; 2017 Apr; 119(4):515-521. PubMed ID: 28058780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2019 Feb; 38(2):563-571. PubMed ID: 30653737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
    Gross T; Schneider MP; Bachmann LM; Blok BF; Groen J; Hoen LA; Castro-Diaz D; Padilla Fernández B; Del Popolo G; Musco S; Hamid R; Ecclestone H; Karsenty G; Phé V; Pannek J; Kessler TM
    Eur Urol; 2016 Jun; 69(6):1102-11. PubMed ID: 26831506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of the neuro-urological patient: a systematic review.
    Averbeck MA; Madersbacher H
    BJU Int; 2015 Apr; 115 Suppl 6():39-46. PubMed ID: 25891319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
    Schneider MP; Gross T; Bachmann LM; Blok BF; Castro-Diaz D; Del Popolo G; Groen J; Hamid R; Karsenty G; Pannek J; Hoen L'; Kessler TM
    Eur Urol; 2015 Nov; 68(5):859-67. PubMed ID: 26194043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review.
    Musco S; Padilla-Fernández B; Del Popolo G; Bonifazi M; Blok BFM; Groen J; 't Hoen L; Pannek J; Bonzon J; Kessler TM; Schneider MP; Gross T; Karsenty G; Phé V; Hamid R; Ecclestone H; Castro-Diaz D
    Neurourol Urodyn; 2018 Jun; 37(5):1522-1540. PubMed ID: 29392753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
    De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.
    Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V
    Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
    Castel-Lacanal E; Gamé X; De Boissezon X; Guillotreau J; Braley-Berthoumieux E; Terracol C; Gasq D; Labrunee M; Viala F; Rischmann P; Clanet M; Marque P
    World J Urol; 2013 Dec; 31(6):1445-50. PubMed ID: 23292297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up.
    Ginsberg DA; Boone TB; Cameron AP; Gousse A; Kaufman MR; Keays E; Kennelly MJ; Lemack GE; Rovner ES; Souter LH; Yang CC; Kraus SR
    J Urol; 2021 Nov; 206(5):1106-1113. PubMed ID: 34495688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
    Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
    BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep brain stimulation effects on lower urinary tract function: Systematic review and meta-analysis.
    Jörg E; Sartori AM; Hofer AS; Baumann CR; Kessler TM
    Parkinsonism Relat Disord; 2020 Oct; 79():65-72. PubMed ID: 32889502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenic Lower Urinary Tract Dysfunction in Adults with Cerebral Palsy: Outcomes following a Conservative Management Approach.
    Goldfarb RA; Pisansky A; Fleck J; Hoversten P; Cotter KJ; Katorski J; Liberman D; Elliott SP
    J Urol; 2016 Apr; 195(4 Pt 1):1009-13. PubMed ID: 26498055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report.
    Çetinel B; Tarcan T; Demirkesen O; Özyurt C; Şen İ; Erdoğan S; Siva A
    Neurourol Urodyn; 2013 Nov; 32(8):1047-57. PubMed ID: 23757108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.
    Sakakibara R
    Clin Auton Res; 2019 Jun; 29(3):313-320. PubMed ID: 30076494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder management in multiple sclerosis.
    Yang CC
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):673-86. PubMed ID: 24314685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.